Coronavirus outbreak and potential impact on clinical data
Dacima collaborates with research institutes and government agencies to enhance healthcare services during the COVID-19 pandemic. Our secure, efficient, and cost-effective EDC platform accelerates outbreak research and response with accurate data collection and analytics.
DACIMA providing randomization (IWRS), supply management and drug accountability software for the COLCORONA trial on COVID-19
Dacima Clinical Suite’s web randomization, supply management, and drug accountability modules are powering the COLCORONA trial by the Montreal Heart Institute, funded by the Quebec government. Dacima remains committed to supporting COVID-19 research with its flexible, cloud-based EDC platform designed for efficient and user-friendly study databases.